Sweden-based KDventures AB today announced that its portfolio company PharmNovo has completed a capital raise of ...
Amprion and Modality.AI have formed a collaboration to explore the combined use of molecular biomarkers and artificial ...
Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...
GSK (LSE: GSK) has terminated its neurodegeneration collaboration with Alector (Nasdaq: ALEC), ending an alliance established ...
A clinical-stage biopharmaceutical company pioneering immunometabolism-based therapies to treat chronic autoimmune and inflammatory diseases through oral small molecules that modulate immune cell ...
Israeli drugmaker Teva Pharmaceutical Industries has expanded its biosimilars pipeline through a global licensing agreement ...
India's Dr Reddy's Laboratories today revealed that supplies of its generic semaglutide would remain unavailable in India and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results